GCKR
protein-codingglucokinase regulator
Gene summary
This gene encodes a protein belonging to the GCKR subfamily of the SIS (Sugar ISomerase) family of proteins. The gene product is a regulatory protein that inhibits glucokinase in liver and pancreatic islet cells by binding non-covalently to form an inactive complex with the enzyme. This gene is considered a susceptibility gene candidate for a form of maturity-onset diabetes of the young (MODY). [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~26.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to GCKR variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001486.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 30 | 5 | 40 | ||
| missense | 1 | 151 | 11 | 1 | 164 | |
| nonsense | 8 | 1 | 9 | |||
| start loss | 0 | |||||
| frameshift | 8 | 2 | 10 | |||
| splice donor/acceptor (+/-2bp) | 10 | 10 | ||||
| Total | 0 | 1 | 182 | 44 | 6 | 233 |
Highest pathogenic variant AF is 0.00002974667
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001477.2 | 19 | MANE Select | |
| Ensembl | ENSP00000264717.2 | 19 | MANE Select | |
| Ensembl | ENSP00000416917.1 | 7 | Standard | |
| Ensembl | ENSP00000399463.1 | 8 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| gckr | Danio rerio | Structure: pancreatic B cell Quality: decreased area abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Wnt Signaling Pathway
- Metabolism of carbohydrates
- Metabolism
- Regulation of Glucokinase by Glucokinase Regulatory Protein
- Glycolysis
Biological Process
- obsolete protein import into nucleus, translocation
- carbohydrate metabolic process
- regulation of glycolytic process
- response to fructose
- negative regulation of glucokinase activity
Molecular Function
- enzyme inhibitor activity
- protein binding
- enzyme binding
- carbohydrate binding
- fructose-6-phosphate binding
Cellular Component
- nucleus
- nucleoplasm
- cytoplasm
- mitochondrion
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000264717
- Coding exons
- 19
- Length
- 26846
- Individuals with no LoFs
- 125166
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 582
- Defined
- 125748
- p
- 0.00232
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -1.14 | 399 | 340 | 1.17 | 0.0000200 | 4077 |
| Missense (PolyPhen) | 82 | 82.992 | 0.98805 | 1067 | ||
| Synonymous | -0.980 | 146 | 132 | 1.11 | 0.00000777 | 1256 |
| Loss of Function | 0.832 | 31 | 36.4 | 0.851 | 0.00000213 | 385 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0012 | 0.0012 | notable |
| Latino/Admixed American | 0.0033 | 0.0033 | notable |
| Ashkenazi Jewish | 0.0087 | 0.0088 | notable |
| East Asian | 0.0018 | 0.0019 | notable |
| Finnish | 0.00018 | 0.00018 | rare |
| European (Non-Finnish) | 0.0024 | 0.0023 | notable |
| South Asian | 0.0011 | 0.0011 | notable |
| Other | 0.0037 | 0.0038 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Inhibits glucokinase (GCK) by forming an inactive complex with this enzyme. The affinity of GCKR for GCK is modulated by fructose metabolites: GCKR with bound fructose 6- phosphate has increased affinity for GCK, while GCKR with bound fructose 1-phosphate has strongly decreased affinity for GCK and does not inhibit GCK activity. {ECO:0000269|PubMed:23621087, ECO:0000269|PubMed:23733961}.;
Recessive Scores
- pRec
- 0.187
Intolerance Scores
- LoFtool
- 0.325
- RVIS EVS
- -0.73
- RVIS percentile EVS
- 14.2
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.475
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |